Bladder Cancer
No. |
Designation |
Histologic Type |
| 001 |
5637 |
Carcinoma |
Bone Cancer
No. |
Designation |
Histologic Type |
|---|
| 002 |
KHOS/NP |
Osteosarcoma |
| 003 |
MG63
|
Osteosarcoma |
| 004 |
MNNG/HOS |
Osteosarcoma |
| 005 |
Saos-2 |
Osteosarcoma |
| 006 |
SJSA-1 |
Osteosarcoma, multipotential sarcoma |
| 007 |
U-2 OS |
Osteosarcoma |
Brain Cancer
No. |
Designation |
Histologic Type |
|---|
| 008 |
CCF-STTG1 |
Astrocytoma |
| 009 |
DBTRG-05MG |
Glioblastoma |
| 010 |
SF-763 |
Brain cancer |
| 011 |
SK-N-BE(1) |
Neuroblastoma |
| 012 |
SK-N-SH |
Neuroblastoma |
| 013 |
T98G |
Glioblastoma, multiforme |
| 014 |
U87 MG |
Glioblastoma, astrocytoma |
Breast Cancer
No. |
Designation |
Histologic Type |
|---|
| 015 |
KPL-1 |
Carcinoma |
| 016 |
ZR-75-30 |
Carcinoma, ductal |
| 017 |
BT-20 |
Carcinoma |
| 018 |
BT-474 |
Carcinoma, ductal |
| 019 |
CAMA-1 |
Carcinoma |
| 020 |
MX-1 |
Carcinoma |
| 021 |
MCF-7 |
Adenocarcinoma |
| 022 |
MDA-MB-231 |
Adenocarcinoma |
| 023 |
MDA-MB-361 |
Adenocarcinoma |
| 024 |
KPL-4 |
Carcinoma |
| 025 |
MDA-MB-435S |
Carcinoma, ductal |
| 026 |
MDA-MB-436 |
Adenocarcinoma |
| 027 |
MDA-MB-453 |
Carcinoma |
| 028 |
MDA-MB-157 |
Carcinoma |
| 029 |
HCC2218 |
Carcinoma |
| 030 |
MDA-MB-468 |
Adenocarcinoma |
| 031 |
SK-BR-3 |
Adenocarcinoma |
| 032 |
SW527 |
Carcinoma |
| 033 |
T-47D |
Carcinoma, ductal |
| 034 |
UACC-812 |
Carcinoma, ductal |
| 035 |
ZR-75-1 |
Carcinoma, ductal |
Cervical Cancer
No. |
Designation |
Histologic Type |
|---|
| 036 |
Hela |
Adenocarcinoma |
Colon Cancer
No. |
Designation |
Histologic Type |
|---|
| 037 |
COLO 205 |
Adenocarcinoma, colorectal |
| 038 |
COLO320/DM |
Adenocarcinoma, colorectal |
| 039 |
DLD-1 |
Adenocarcinoma, colorectal |
| 040 |
HCT-15 |
Adenocarcinoma, colorectal |
| 041 |
HCT-8 |
Adenocarcinoma, ileocecal colorectal |
| 042 |
SW480 |
Adenocarcinoma |
| 043 |
HCT-116 |
Carcinoma, colorectal |
| 044 |
HT-29 |
Adenocarcinoma, colorectal |
| 045 |
KM-12 |
Colorectal |
| 046 |
KM202L |
Colorectal |
| 047 |
LoVo |
Colorectal |
| 048 |
LS174T |
Colorectal |
| 049 |
LS411N |
Carcinoma, colorectal |
| 050 |
RKO |
Carcinoma |
| 051 |
SK-CO-1 |
Adenocarcinoma, colorectal |
| 052 |
SW403 |
Adenocarcinoma, colorectal |
| 053 |
SW48 |
Adenocarcinoma, colorectal |
| 054 |
T84 |
Carcinoma, colorectal |
| 055 |
WiDr |
Adenocarcinoma, colorectal |
Gastric Cancer
No. |
Designation |
Histologic Type |
|---|
| 056 |
AGS |
Adenocarcinoma, gastric |
| 057 |
KATO III |
Carcinoma, gastric |
| 058 |
NCI-H1299 |
Carcinoma, gastric |
| 059 |
NCI-N87 |
Carcinoma, gastric |
| 060 |
SGC-7901 |
Carcinoma, gastric |
| 061 |
SNU-16 |
Carcinoma, gastric |
| 062 |
MNK-45 |
Gastric cancer, stomach |
| 063 |
SNU-5 |
Gastric cancer, stomach |
| 064 |
SCH |
Gastric cancer, stomach |
| 065 |
MGC-803 |
Gastric cancer, stomach |
| 066 |
PAMC-82 |
Gastric cancer, stomach |
| 067 |
BGC-823 |
Gastric cancer, stomach |
Kidney Cancer
No. |
Designation |
Histologic Type |
|---|
| 068 |
20B8 |
Epithelial |
| 069 |
769-P |
Adenocarcinoma, renal cell |
| 070 |
786-O |
Adenocarcinoma, renal cell |
| 071 |
A-498 |
Carcinoma |
| 072 |
ACHN |
Adenocarcinoma, renal cell |
| 073 |
Caki-1 |
Carcinoma, clear cell |
| 074 |
G402 |
Leiomyoblastoma, renal |
Leukemia
No. |
Designation |
Histologic Type |
|---|
| 075 |
HL-60 clone15 |
Acute promyelocytic leukemia |
| 076 |
8E5 |
Leukemia, acute lymphoblastic |
| 077 |
ARH-77 |
Leukemia, plasma cell |
| 078 |
BDCM |
Leukemia, acute myelogenous |
| 079 |
CCRF-CEM |
Leukemia, acute lymphoblastic |
| 080 |
CCRF-HSB-2 |
Leukemia, acute lymphoblastic |
| 081 |
CEM/C1 |
Leukemia, acute lymphoblastic |
| 082 |
CEM/C2 |
Leukemia, acute lymphoblastic |
| 083 |
CEM-CM3 |
Leukemia, acute lymphoblastic |
| 084 |
CESS |
Leukemia, myelomonocytic |
| 085 |
D1.1 |
Leukemia, acute T cell, CD4 negative |
| 086 |
GDM-1 |
Leukemia, myelomonoblastic |
| 087 |
I 2.1 |
Leukemia, acute T cell |
| 088 |
I 9.2 |
Leukemia, acute T cell |
| 089 |
J.gamma1 |
Leukemia, acute T cell |
| 090 |
J.gamma1.WT |
Leukemia, acute T cell |
| 091 |
J.RT3-T3.5 |
Leukemia, acute T cell |
| 092 |
J45.01 |
Leukemia, acute T cell, CD45 deficient |
| 093 |
Jurkat, Clone E6-1 |
Leukemia, acute T cell |
| 094 |
JVM-2 |
Leukemia |
| 095 |
K562 |
Leukemia |
| 096 |
Kasumi-1 |
Leukemia, acute myeloblastic |
| 097 |
Kasumi-4 |
Leukemia, chronic myeloblastic |
| 098 |
KIT 225 |
T-cell chronic lymphocytic leukemia |
| 099 |
KE-37 |
Human T cell leukemia |
| 100 |
KG-1 |
Leukemia, acute lymphoblastic |
| 101 |
KG-1a |
Leukemia, acute lymphoblastic |
| 102 |
KU812 |
Leukemia, chronic myelogenous |
| 103 |
Loucy |
Leukemia, acute lymphoblastic t(16;20) translocation |
| 104 |
ML-1 |
Leukemia |
| 105 |
MEG-01 |
Leukemia, chronic myelogenous |
| 106 |
MHH-CALL2 |
Leukemia |
| 107 |
Mo |
Leukemia, hairy cell |
| 108 |
MOLT-3 |
Leukemia, acute lymphoblastic |
| 109 |
MOLT-4 |
Leukemia, acute lymphoblastic |
| 110 |
MV-4-11 |
Leukemia, biphenotypic B myelomonocytic |
| 111 |
P116 |
Leukemia, acute T cell |
| 112 |
P116.cl39 |
Leukemia, acute T cell |
| 113 |
REH |
Leukemia, acute lymphocytic (non-T, non-B) |
| 114 |
RS4;11 |
Leukemia, acute lymphoblastic, t(4;11) translocation |
| 115 |
SUP-B15 |
Leukemia, acute lymphoblastic |
| 116 |
SUP-T1 |
Leukemia, lymphoblastic |
Liver Cancer
No. |
Designation |
Histologic Type |
| 117 |
Bel-7402 |
Carcinoma |
| 118 |
Bel-7405 |
Carcinoma |
| 119 |
Bel-7404 |
Carcinoma |
| 120 |
HEP-3B |
Carcinoma |
| 121 |
HepG2 |
Carcinoma |
| 122 |
QGY-7701 |
Hepatoma carcinoma |
| 123 |
QGY-7703 |
Hepatoma carcinoma |
| 124 |
QSG-7701 |
Hepatoma carcinoma |
| 125 |
SK-HEP-1 |
Adenocarcinoma |
| 126 |
SMMC-7721 |
Hepatoma cancer |
| 127 |
SNU-398 |
Hepatocellular carcinoma |
| 128 |
SNU-449 |
Hepatocellular carcinoma |
| 129 |
HLE |
Hepatocellular carcinoma |
| 130 |
HUH-7 |
Hepatocellular carcinoma |
Lung Cancer
No. |
Designation |
Histologic Type |
|---|
| 131 |
A-427 |
Carcinoma |
| 132 |
A549 |
Carcinoma |
| 133 |
Calu-3 |
Adenocarcinoma |
| 134 |
MSTO-211H |
Mesothelioma, biphasic lung cancer |
| 135 |
NCI-H1395 |
Adenocarcinoma |
| 136 |
NCI-H1417 |
Carcinoma, classic small cell lung cancer |
| 137 |
NCI-H1975 |
Adenocarcinoma, non-small cell lung cancer |
| 138 |
NCI-H2122 |
Adenocarcinoma, non-small cell lung cancer |
| 139 |
NCI-H23 |
Non-small cell lung cancer |
| 140 |
NCI-H226 |
Carcinoma, squamous cell mesothelioma |
| 141 |
NCI-H292 |
Carcinoma, mucoepidermoid pulmonary |
| 142 |
NCI-H358 |
Carcinoma, bronchioalveolar, non-small cell lung cancer |
| 143 |
NCI-H460 |
Carcinoma, large cell |
| 144 |
PLA801-95D |
Carcinoma, large cell |
| 145 |
NCI-H526 |
Carcinoma, variant small cell |
| 146 |
NCI-H727 |
Bronchial carcinoid lines |
| 147 |
NCI-H82 |
Carcinoma, small cell lung cancer |
| 148 |
SK-LU-1 |
Adenocarcinoma |
| 149 |
SW1573 |
Carcinoma |
|
Lymphoma
No. |
Designation |
Histologic Type |
| 150 |
2B8 |
Lymphoma, Burkitt's |
| 151 |
BC-1 |
Lymphoma, EBV and KSHV positive |
| 152 |
BC-2 |
Lymphoma, EBV and KSHV positive |
| 153 |
BCP-1 |
Lymphoma, body cavity based |
| 154 |
CA46 |
Lymphoma, Burkitt's |
| 155 |
Daudi |
Lymphoma, Burkitt's |
| 156 |
DG-75 |
Lymphoma, Burkitt's |
| 157 |
DOHH2 |
Lymphoma |
| 158 |
EB1 |
Lymphoma, Burkitt's |
| 159 |
EB2 |
Lymphoma, Burkitt's |
| 160 |
EB-3 |
Lymphoma, Burkitt's |
| 161 |
EOL-1 |
Lymphoma |
| 162 |
GA-10 |
Lymphoma, Burkitt's |
| 163 |
GA-10 (Clone 4) |
Lymphoma, Burkitt's |
| 164 |
GK-5 |
B lymphoblast; Epstein-Barr virus (EBV) transformed |
| 165 |
H9 |
Lymphoma, cutaneous |
| 166 |
HH |
Lymphoma, cutaneous T cell |
| 167 |
HKB-11 |
Lymphoma, Burkitt's |
| 168 |
HT |
Lymphoma, diffuse mixed |
| 169 |
HuT 102 |
Lymphoma |
| 170 |
HuT 78 |
Lymphoma |
| 171 |
Jiyoye |
Lymphoma, Burkitt's |
| 172 |
MC116 |
Lymphoma, undifferentiated |
| 173 |
MJ |
Lymphoma, cutaneous T cell, mycosis fungoides |
| 174 |
ML-2 |
Lymphoma |
| 175 |
NC-37 |
Human lymphoma cell line |
| 176 |
NK-92 |
Lymphoma, non-Hodgkin's |
| 177 |
NK-92 MI |
Malignant non-Hodgkin's lymphoma |
| 178 |
P3HR-1 |
Lymphoma, Burkitt's |
| 179 |
Raji |
Lymphoma, Burkitt's |
| 180 |
Ramos (RA 1) |
Lymphoma, Burkitt's |
| 181 |
Ramos.2G6.4C10 |
Lymphoma, Burkitt's |
| 182 |
RL |
Lymphoma, non-Hodgkin's |
| 183 |
SR |
Lymphoma, large cell immunoblastic |
| 184 |
ST486 |
Lymphoma, Burkitt's |
| 185 |
TALL-1 |
Lymphoma, T cell |
| 186 |
TO 175.T |
Lymphoma, Hodgkin's |
| 187 |
Toledo |
Lymphoma, diffuse large cell, non-Hodgkin's B cell |
| 188 |
U-937 |
Lymphoma, histiocytic |
| 189 |
TF-1 |
Erythroleukemia |
Mesothelioma
No. |
Designation |
Histologic Type |
|---|
| 190 |
Miller H2373 |
Mesothelioma |
| 191 |
Milot H2452 |
Mesothelioma |
| 192 |
H2595 |
Mesothelioma |
| 193 |
NCI-H28 |
Mesothelioma |
Multiple Myeloma
No. |
Designation |
Histologic Type |
|---|
| 194 |
RPMI 8226 |
Plasmacytoma, myeloma |
| 195 |
NCI-H929 |
Plasmacytoma, myeloma |
Oral Cancer
No. |
Designation |
Histologic Type |
|---|
| 196 |
CAL 27 |
Carcinoma, squamous cell |
Ovary Cancer
No. |
Designation |
Histologic Type |
|---|
| 197 |
2774 |
Ovarian carcinoma |
| 198 |
COLO720E |
Human B lymphoblastoid cells (from patient with adenocarcinoma) |
| 199 |
COV434 |
Human ovarian granulosa tumour cell line established from a solid primary tumour |
| 200 |
COV504 |
Human ovarian epithelial-serous carcinoma cell line established from a pleural effusion |
| 201 |
COV644 |
Human ovarian epithelial-mucinous carcinoma cell line established from a solid primary tumour |
| 202 |
EFO-21 |
Cystadenocarcinoma |
| 203 |
EFO-27 |
Adenocarcinoma |
| 204 |
ES-2 |
Carcinoma, clear cell |
| 205 |
HO-8910 |
Ovarian |
| 206 |
KURAMOCHI |
Ovarian |
| 207 |
OV56 |
Human ovarian serous carcinoma (ascites) stage IV, poorly differentiated |
| 208 |
OV90 |
Malignant papillary serous adenocarcinoma |
| 209 |
OVCAR-3 |
Adenocarcinoma |
| 210 |
OVCAR-4 |
Ovarian carcinoma |
| 211 |
OVISE |
Ovarian carcinoma |
| 212 |
OVSAHO |
Ovarian carcinoma |
| 213 |
OVTOKO |
Ovarian carcinoma |
| 214 |
PA-1 |
Teratocarcinoma |
| 215 |
SK-OV-3 |
Adenocarcinoma |
| 216 |
SW626 |
Adenocarcinoma |
| 217 |
TOV-112D |
Adenocarcinoma, malignant, endometrioid carcinoma |
| 218 |
TOV-21G |
Adenocarcinoma, malignant, clear cell carcinoma |
Pancreatic Cancer
No. |
Designation |
Histologic Type |
|---|
| 219 |
AsPc-1 |
Adenocarcinoma |
| 220 |
BxPC-3 |
Adenocarcinoma |
| 221 |
Capan-1 |
Adenocarcinoma |
| 222 |
Capan-2 |
Adenocarcinoma |
| 223 |
CFPAC-1 |
Adenocarcinoma, ductal; cystic fibrosis |
| 224 |
Hs766T |
Pancreatic carcinoma |
| 225 |
KP1 |
Pancreatic carcinoma |
| 226 |
KP2 |
Pancreatic carcinoma |
| 227 |
KP3 |
Pancreatic carcinoma |
| 228 |
KP4 |
Pancreatic carcinoma |
| 229 |
Miapaca2 |
Pancreatic carcinoma |
| 230 |
PANC-1 |
Carcinoma, epithelioid |
| 231 |
PSN1 |
Pancreatic carcinoma |
Prostate Cancer
No. |
Designation |
Histologic Type |
|---|
| 232 |
22Rv1 |
Carcinoma |
| 233 |
DU 145 |
Carcinoma |
| 234 |
LNCaP |
Carcinoma |
| 235 |
PC-3 |
Adenocarcinoma |
Rhabdomyosarcoma
No. |
Designation |
Histologic Type |
|---|
| 236 |
A-204 |
Rhabdomyosarcoma |
| 237 |
RD |
Rhabdomyosarcoma |
| 238 |
RMS13 |
Rhabdomyosarcoma |
Skin Cancer
No. |
Designation |
Histologic Type |
|---|
| 239 |
A101D |
Melanoma |
| 240 |
A2058 |
Melanoma, malignant |
| 241 |
A375 |
Melanoma, malignant |
| 242 |
A431 |
Epidermoid carcinoma (skin) |
| 243 |
C32 |
Melanoma, amelanotic |
| 244 |
COLO 829 |
Melanoma, malignant |
| 245 |
MeWo |
Melanoma, malignant |
| 246 |
MEL-HO |
Melanoma, malignant |
| 247 |
G-361 |
Melanoma, malignant |
| 248 |
WM-115 |
Melanoma |
| 249 |
Hs-294T |
Melanoma, malignant |
| 250 |
HT-144 |
Melanoma, malignant |
| 251 |
M14 |
Melanoma, amelanotic |
| 252 |
SH-4 |
Melanoma |
| 253 |
SK-MEL-30 |
Melanoma, malignant |
| 254 |
SK-MEL-2 |
Melanoma, malignant |
| 255 |
SK-MEL-24 |
Melanoma, malignant |
| 256 |
SK-MEL-28 |
Melanoma, malignant |
| 257 |
SK-MEL-5 |
Melanoma, malignant |
| 258 |
UACC-62 |
Melanoma |
Synovial Sarcoma
No. |
Designation |
Histologic Type |
|---|
| 259 |
SW 982 |
Sarcoma, synovial |
Thyroid Cancer
No. |
Designation |
Histologic Type |
|---|
| 260 |
HTC-C3 |
Carcinoma |
Uterine Sarcoma
No. |
Designation |
Histologic Type |
|---|
| 261 |
SK-UT-1 |
Leiomyosarcoma |
| 262 |
MES-SA |
Sarcoma, uterine |
| 263 |
MES-SA/Dx-5 |
Sarcoma, uterine |
Miscellaneous
No. |
Designation |
Histologic Type |
|---|
| 264 |
FaDu |
Carcinoma, squamous cell |
| 265 |
HT-1080 |
Fibrosarcoma |
| 266 |
JAR |
Choriocarcinoma |
| 267 |
SW 872 |
Liposarcoma |
| 268 |
SW837 |
Adenocarcinoma |
|
Quotation and Ordering
 For questions, or to inquire about the status of your order, please contact us by email, phone, fax or via our Secure Online Messaging System.
| To allow us to provide you with a comprehensive quotation, please download and complete the Quotation/Order Form, and send it to us by email, fax, or via our Secure Online Ordering System. |
 |
To place an order, please send us a formal PO (Purchase Order) or credit card information with our quotation number by email or fax. You can also submit PO/credit card information by phone or via our Secure Online Messaging System.
Our customer service representatives are available 24 hours a day, Monday through Friday to assist you.
|
